The evolution of clinical research in thalassaemia: where has all the funding gone?
- PMID: 33094840
- DOI: 10.1111/bjh.17094
The evolution of clinical research in thalassaemia: where has all the funding gone?
Keywords: epidemiology; haemoglobinopathies; morbidity; survival.
Comment on
-
Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.Br J Haematol. 2020 Dec;191(5):897-905. doi: 10.1111/bjh.17091. Epub 2020 Oct 23. Br J Haematol. 2020. PMID: 33094842
References
-
- Jobanputra M, Paramore C, Laird SG, McGahan M, Telfer P. Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis. Br J Haematol. 2020.
-
- Dhanya R, Sedai A, Ankita K, Parmar L, Agarwal RK, Hegde S, et al. Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India. Blood Adv. 2020;4(7):1448-57. https://doi.org/10.1182/bloodadvances.2019000760
-
- Vitrano A, Calvaruso G, Lai E, Colletta G, Quota A, Gerardi C, et al. The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy? Br J Haematol. 2017;176(1):124-30.
-
- Pinto VM, Poggi M, Russo R, Giusti A, Forni GL. Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience. Blood Rev. 2019;38:100594.
-
- Piel FB, Tatem AJ, Huang Z, Gupta S, Williams TN, Weatherall DJ. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. Lancet Glob Health. 2014;2(2):e80-e89.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
